BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS
申请人:Singh Jasbir
公开号:US20090324569A1
公开(公告)日:2009-12-31
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula I:
A particular embodiment is
BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
申请人:SINGH Jasbir
公开号:US20120213758A1
公开(公告)日:2012-08-23
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id:
A particular embodiment is
Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
申请人:Singh Jasbir
公开号:US08791267B2
公开(公告)日:2014-07-29
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula I:
A particular embodiment is
Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
申请人:Decode Genetics EHF
公开号:EP2628727A2
公开(公告)日:2013-08-21
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id:
or salt thereof, in particular a pharmaceutically acceptable salt thereof.
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula I: